Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sivelestat Sodium for Pulmonary Insufficiency After Aortic Dissection Arch Surgery
NCT05343338Unknown
- Sponsor
- First Affiliated Hospital of Xi'an Jiaotong University
- Start
- Apr 2022
- Primary completion
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial in acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) comparing Sivelestat sodium + Standard of Care with Standard of Care (2 arms). Primary endpoint: Incidence of respiratory insufficiency (PaO2/FiO2 <= 200mmHg). Status: unknown.
02
Drugs
sivelestat
03
Conditions
acute lung injury (ALI)acute respiratory distress syndrome (ARDS)
Beyond the preview
Go deeper on NCT05343338.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05343338.